You are viewing an incomplete version of our website. Please click to reload the website as full version.

Navigieren Sie durch unsere anti-PAG1 (PAG1) Antikörper

Full name:
anti-phosphoprotein Associated with Glycosphingolipid Microdomains 1 Antikörper (PAG1)
Auf finden Sie aktuell 98 phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) Antikörper von 11 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen PAG1 Proteine (4) und PAG1 Kits (3) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 108 PAG1 Produkte verfügbar.
8430414N03Rik, Cbp, F730007C19Rik, IGFBP-4ase, MGC80192, Pag, PAG1, PAPP-A

Alle verfügbaren anti-PAG1 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-PAG1 Antikörper

  1. Human Monoclonal PAG1 Primary Antibody für FACS, IHC (p) - ABIN94272 : Yerly, Ding, Tauzin, van Echten-Deckert, Borisch, Hoessli: The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome. in European journal of haematology 2010 (PubMed)
    Zeige alle 6 Referenzen für ABIN94272

  2. Human Monoclonal PAG1 Primary Antibody für IHC (p), IP - ABIN94270 : Baumgartner, Angelisová, Setterblad, Mooney, Werling, Horejsí, Langsley: Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. in Blood 2003 (PubMed)
    Zeige alle 5 Referenzen für ABIN94270

  3. Cow (Bovine) Monoclonal PAG1 Primary Antibody für IHC (p), IP - ABIN269119 : Yamashita, Chattopadhyay, Fensterl, Zhang, Sen: A TRIF-independent branch of TLR3 signaling. in Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)

  4. Human Monoclonal PAG1 Primary Antibody für FACS, IHC (p) - ABIN120652 : Brdicková, Brdicka, Andera, Spicka, Angelisová, Milgram, Horejsí: Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. in FEBS letters 2001 (PubMed)

Weitere Antikörper gegen PAG1 Interaktionspartner

Human phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) Interaktionspartner

  1. Up-regulated expression of CBP (zeige CREBBP Antikörper) in Jurkat cells could reduce cell homogeneity and promote cell apoptosis

  2. No association Pag1 mutation with patient with Schizophrenia.

  3. The risk-associated allele of rs2370615 predisposes to allergic disease by increasing PAG1 expression, which might promote B cell activation (zeige BLNK Antikörper) and have a pro-inflammatory effect.

  4. CBP (zeige CREBBP Antikörper) may decrease the metastasis of esophageal carcinoma by inhibiting the activation of Src (zeige SRC Antikörper).

  5. The inhibitory function of novobiocin in disrupting the HIF1alpha (zeige HIF1A Antikörper)/p300 (zeige EP300 Antikörper) complex might be important in tumor cell growth.

  6. siRNA directed against PAG1 in a radioresistant (Hep-2max) cell line dramatically enhanced the radiosensitivity and IR-induced cell death.

  7. expression of CBP (zeige CREBBP Antikörper) gene is decreased in esophageal carcinoma, which might contribute to the tumorigenesis and progression.

  8. An over-expression of PAG1 in PC-3M-1E8 cells effectively suppresses the activation of Ras and ERK (zeige EPHB2 Antikörper), as well as the cyclin D1 (zeige CCND1 Antikörper) expression, leading to an inhibition of the proliferation ability of tumor cells.

  9. Cbp (zeige CREBBP Antikörper) down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK (zeige MAPK1 Antikörper)/PI3K (zeige PIK3CA Antikörper) pathways in a subset of cancer cells.

  10. Results indicate that Cbp is required for the Csk-mediated inactivation of c-Src and may control the promotion of malignancy in NSCLC tumors that are characterized by c-Src upregulation.

Mouse (Murine) phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) Interaktionspartner

  1. Study demonstrates proof-of-principle and provides feasibility for a novel therapeutic strategy to inhibit atherosclerotic plaque burden by selective targeting of PAPP-A (zeige PAPPA Antikörper).

  2. stimulation of PAPP-A (zeige PAPPA Antikörper) expression by intermittent PTH (zeige PTH Antikörper) treatment contributes to PTH (zeige PTH Antikörper) bone anabolism in mice

  3. PAPP-A (zeige PAPPA Antikörper) affects fascicle structure, thereby affecting tendon phenotype.

  4. This study demonstrated that cbp (zeige CREBBP Antikörper) increase in skeletal muscle in muscle atrophy.

  5. PAG is constitutively phosphorylated in resting T cells and rapidly dephosphorylated once the TCR is engaged.

  6. If Cbp enhances the interaction between c-Src and FAK, Cbp could promote c-Src function when lipid rafts are disrupted.

  7. PAG (zeige PRDX1 Antikörper) can function as both a positive and a negative regulator of mast cell signaling, depending upon the signaling pathway involved. PAG (zeige PRDX1 Antikörper) is a positive regulator of passive systemic anaphylaxis.

  8. PAPP-A (zeige PAPPA Antikörper) has a role in development of advanced plaque with necrotic cores and buried fibrous caps (zeige CAPS Antikörper) in the brachiocephalic artery

  9. these data indicate preferential impact of PAPP-A (zeige PAPPA Antikörper) deficiency on visceral fat in the mouse that is associated with enhanced insulin receptor (zeige INSR Antikörper) signaling

  10. Studies show a conditional PAPP-A (zeige PAPPA Antikörper) knockout (KO) model for efficacy of tamoxifen-induced floxed PAPP-A (zeige PAPPA Antikörper) excision in various tissues and indicate a significant reduction of neointimal formation after unilateral carotid artery ligation.

PAG1 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a type III transmembrane adaptor protein that binds to the tyrosine kinase csk protein. It is thought to be involved in the regulation of T cell activation.

Alternative names and synonyms associated with PAG1

  • phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) Antikörper
  • phosphoprotein associated with glycosphingolipid microdomains 1 (pag1) Antikörper
  • phosphoprotein associated with glycosphingolipid microdomains 1 (Pag1) Antikörper
  • pregnancy-associated plasma protein A (Pappa) Antikörper
  • 8430414N03Rik Antikörper
  • Cbp Antikörper
  • F730007C19Rik Antikörper
  • IGFBP-4ase Antikörper
  • MGC80192 Antikörper
  • Pag Antikörper
  • PAG1 Antikörper
  • PAPP-A Antikörper

Bezeichner auf Proteinebene für PAG1

phosphoprotein associated with glycosphingolipid microdomains 1 , phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like , Csk-binding protein , phosphoprotein associated with glycosphingolipid-enriched microdomains 1 , transmembrane adapter protein PAG , transmembrane adaptor protein PAG , transmembrane phosphoprotein Cbp , Csk binding protein , csk-binding protein , phosphoprotein transmembrane adaptor 1 , phosphoprotein-associated with GEMs , IGF-dependent IGFBP-4 protease , insulin-like growth factor-dependent IGF-binding protein 4 protease , pappalysin-1

420195 Gallus gallus
446514 Xenopus laevis
464253 Pan troglodytes
610895 Canis lupus familiaris
700748 Macaca mulatta
100050548 Equus caballus
100380123 Xenopus (Silurana) tropicalis
100391406 Callithrix jacchus
100585162 Nomascus leucogenys
55824 Homo sapiens
614460 Bos taurus
64019 Rattus norvegicus
94212 Mus musculus
100157912 Sus scrofa
101112826 Ovis aries
18491 Mus musculus
Ausgewählte Anbieter für anti-PAG1 (PAG1) Antikörper
Haben Sie etwas anderes gesucht?